Annual Accounts Receivable
$452.50M$36.52M-7.47%
Summary
- Current Value
- As of today, BIO annual accounts receivable is $452.50M, down -7.47% on
- Historical Performance
- BIO annual accounts receivable is up +6.84% over the past 3 years, and up +15.24% over the past 5 years
- All-Time High Comparison
- BIO annual accounts receivable is currently -8.52% below its historical high of $494.65M set on
- 3-Year Low Comparison
- BIO annual accounts receivable is at its 3-year low
- Sector Comparison
- BIO annual accounts receivable is higher than 85.94% of companies in Healthcare sector
Annual Accounts Receivable Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Accounts Receivable | $452.50M | -7.5% | +6.8% | +15.2% | +30.9% | |
| Quarterly Accounts Receivable | $464.70M | +0.6% | +7.5% | +15.5% | +26.1% | |
| Price | $324.09 | -5.9% | -22.6% | -47.8% | +208.4% | |
| Annual Accounts Payable | $122.30M | -14.4% | -13.8% | +14.3% | +31.5% | |
| Annual Current Assets | $3.03B | -0.6% | +52.2% | +39.0% | +93.9% | |
| Annual Revenue | $2.57B | -3.9% | -12.2% | +11.0% | +43.8% | |
| Annual Net Income | -$1.84B | -189.4% | -143.3% | -204.9% | -1336.3% | |
| Annual Cash & Cash Equivalents | $1.67B | +3.3% | +90.3% | +48.7% | +123.7% |
Annual Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $494.65M | N/A | -8.5% |
| 5Y | $494.65M | -8.5% | |
| All | $494.65M | -8.5% |
Annual Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $452.50M | at low | |
| 5Y | $419.42M | N/A | +7.9% |
| All | $182.24M | +148.3% |
Annual Accounts Receivable History
FAQ
What is the current annual accounts receivable of BIO?
As of today, BIO annual accounts receivable is $452.50M
What is 1-year change in BIO annual accounts receivable?
BIO annual accounts receivable is down -7.47% year-over-year
What is 3-year change in BIO annual accounts receivable?
BIO annual accounts receivable is up +6.84% over the past 3 years
How far is BIO annual accounts receivable from its all-time high?
BIO annual accounts receivable is currently -8.52% below its historical high of $494.65M set on December 31, 2022
How does BIO annual accounts receivable rank versus sector peers?
BIO annual accounts receivable is higher than 85.94% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly Accounts Receivable
$464.70M$5.20M-1.11%
Summary
- Current Value
- As of today, BIO quarterly accounts receivable is $464.70M, down -1.11% on
- Historical Performance
- BIO quarterly accounts receivable is up +0.60% year-over-year, and up +7.49% over the past 3 years
- All-Time High Comparison
- BIO quarterly accounts receivable is currently -6.74% below its historical high of $498.27M set on
- 3-Year Low Comparison
- BIO quarterly accounts receivable is +9.42% above its 3-year low of $424.70M reached on
- Sector Comparison
- BIO quarterly accounts receivable is higher than 86.85% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Accounts Receivable | $464.70M | -1.1% | +0.6% | +7.5% | +15.5% | |
| Annual Accounts Receivable | $452.50M | – | -7.5% | +6.8% | +15.2% | |
| Price | $324.09 | +7.0% | -5.9% | -22.6% | -47.8% | |
| Quarterly Accounts Payable | $128.80M | -7.5% | +5.4% | -9.8% | -3.1% | |
| Quarterly Current Assets | $2.84B | +1.1% | -7.0% | -9.5% | +22.3% | |
| Quarterly Revenue | $653.00M | +0.2% | +0.5% | -4.1% | +0.9% | |
| Quarterly Net Income | -$341.90M | -207.6% | -152.3% | -110.0% | -126.0% | |
| Quarterly Cash & Cash Equivalents | $1.42B | +3.3% | -12.8% | -23.4% | +22.1% |
Quarterly Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $469.90M | -1.1% | |
| 3Y | $498.27M | -6.7% | |
| 5Y | $498.27M | -6.7% | |
| All | $498.27M | -6.7% |
Quarterly Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $424.70M | +9.4% | |
| 3Y | $424.70M | +9.4% | |
| 5Y | $399.31M | +16.4% | |
| All | $88.22M | +426.8% |
Quarterly Accounts Receivable History
FAQ
What is the current quarterly accounts receivable of BIO?
As of today, BIO quarterly accounts receivable is $464.70M
What is BIO quarterly accounts receivable most recent change?
BIO quarterly accounts receivable was down -1.11% on September 30, 2025
What is 1-year change in BIO quarterly accounts receivable?
BIO quarterly accounts receivable is up +0.60% year-over-year
How far is BIO quarterly accounts receivable from its all-time high?
BIO quarterly accounts receivable is currently -6.74% below its historical high of $498.27M set on March 31, 2023
How does BIO quarterly accounts receivable rank versus sector peers?
BIO quarterly accounts receivable is higher than 86.85% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio